Self-Care with Bioenergy for Macular Degeneration: An Update by Michael Mannion
Amber (a pseudonym) was diagnosed with intermediate dry macular degeneration (AMD) in April 2021. This condition—the most common cause of blindness among seniors–affects 20 million Americans and there is no effective treatment available. But five years after her initial diagnosis, Amber is well. She has experienced a complete remission of the fatty deposits called drusen which determine the extent of loss of vision with AMD. She has accomplished this through the use of a bioenergy approach developed by Wilhelm Reich, MD.
In addition to the resorption of the drusen associated with her AMD, Amber has experienced improvement in her visual acuity from 20/60 and 20/40 to 20/35 and 20/30, as well as other improvements in eye health. Her use of this bioenergy technique is responsible for this as well. Every physician who has seen Amber’s before-and-after retinal scans has used one word to describe them–Amazing! They are amazing but they are also irrefutable evidence of healing and the need for a pilot study.
About the Proposed Pilot Study
Our proposed pilot study will examine the effectiveness of bioenergy in self-care for this condition. Two patients have already experienced healing using this approach. And a third is improving and continuing to use this self-care modality. Their results are the impetus for the study which will be led by two highly accomplished professionals: Garret Yount, PhD, a renowned research scientist; and Irene A. Barbazetto, MD, an internationally recognized specialist in AMD.
In early October 2024, Amber met with Dr Yount to discuss her use of bioenergy for her macular degeneration to see if he would like to conduct a study to determine if what she is doing might be of help to others with her condition. He was very interested and agreed to undertake a pilot study. He has over 80 published papers in peer-reviewed journals and is one of only a few scientists to receive an NIH R01 top-tier grant to study the human bioenergy field. Dr Yount understands that this approach has already shown a positive healing impact on Amber. He is an independent, open-minded scientist who knows that bioenergy (or orgone energy) is a real phenomenon. The challenge is to discover how effective it can be with this condition.
After managing Trish’s care since April 2021, Dr Barbazetto has joined the pilot study. She will collect data on the use of orgone energy for self-care for intermediate dry macular degeneration. Dr Barbazetto will use her decades of experience as an expert clinician treating patients with AMD, along with her expertise as an investigator on national and international medical trials, to evaluate the clinical data being collected during the pilot study.
In its first phase, the pilot study will enroll 20 people with AMD in a study using an orgone energy device for 12 months. We are confident that the results will support the need for a second phase of the pilot study. It will be a blind study with two groups: half of the participants will use an orgone energy funnel and half will use a look-a-like placebo device. We are inspired to undertake this project because of positive results already achieved. We hope that positive results with this pilot study will open the door to other clinical trials of orgone energy in healing; a door that has been shut tight for decades.
About The Research Team
Garret Yount, PhD, is a Scientist at the Institute of Noetic Sciences (IONS) where his research focuses on mapping the mind-gene interface. In 1997, Dr. Yount was among the first scientists to be awarded a Research Project Grant (R01) from the National Institutes of Health to study qigong and other healing modalities involving the human biofield. He obtained his BS from the Department of Molecular & Cell Biology at the Pennsylvania State University, and his PhD from the Department of Neurobiology & Behavior at the State University of New York at Stony Brook. He was then awarded two Postdoctoral Scholarships, and a Fellowship for Pediatric Cancer Research in New York. Dr. Yount has a long-standing interest in developing methods and technologies for bridging molecular neurobiology with aspects of consciousness and extended human capacities. His doctoral thesis work in Stony Brook focused on deciphering molecular links between brain activity and the regulation of neuropeptide gene expression.
Irene A Barbazetto, MD is an internationally recognized expert in the treatment of macular degeneration, retinal vascular disease, retinal vein occlusion, hereditary retinal disease, and diabetes. The author of more than 40 peer-reviewed articles and book chapters, she serves on the Editorial Board of the prestigious journal Graefe’s Archive of Clinical and Experimental Ophthalmology. Dr. Barbazetto is the recipient of the 2009 Achievement Award from the American Academy of Ophthalmology. In addition to her clinical work, Dr. Barbazetto serves as an investigator on a number of national and international medical trials. She is a pioneer in the use of photodynamic therapy in the treatment of choroidal hemangioma and other ocular tumors and an active reviewer for several ophthalmologic publications. Her patients voted her as one of the best retina doctors, America’s “Most Compassionate Physicians,” and she received the “Patient’s Choice Award” in 2010. Her academic affiliations include Columbia University, NYU, and Manhattan Eye and Ear Hospital.
To learn more about Amber’s healing; the bioenergy self-care involved; the pilot study and how you can contribute to bringing it about, visit the website of The Mindshift Institute at www.mindshiftinstitute.org
Mr. Mannion has been a professional health and medical writer for over 35 years, working with major conventional and complementary health organizations and practitioners. He was formerly the Director of Professional Education Publications for the American Cancer Society and the Managing Editor of the Society’s flagship journal. He is the author of a number of works of nonfiction, among them A Maverick’s Odyssey: One Doctor’s Quest to Conquer Disease – The Story of Stephen L. DeFelice, M.D. and the Foundation for Innovation in Medicine; The New American Medicine; Frankenstein Foods; The Pharmacist’s Guide to Over-the-Counter and Natural Remedies; How to Help Your Teenager Stop Smoking; and Project Mindshift: The Reeducation of the American Public Concerning Extraterrestrial Life. He is also the author of three novels, Death Cloud; Colleen; and Erin’s Daughters.
Patricia B. Corbett and Michael Mannion are the co-founders of The Mindshift Institute which has produced over two dozen events in New York City and at the invitation of organizations such as the Center for Psychology & Social Change in Cambridge, MA; Friends of the Institute of Noetic Sciences in New York, and member groups of the Institute of Noetic Sciences in California and Connecticut. For four years, they ran the Center for New Knowledge in Northampton, MA. And for 10 years (2003-2012), they produced an annual Mindshift conference in Rangeley, ME called Cosmos and Consciousness. For more information, visit their website at www.mindshiftinstitute.org